On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Centre François Baclesse

InstitutionResearch output, impact & collaborations

Centre François Baclesse is a institution indexed in ScholarIQ from OpenAlex.

What is known about Centre François Baclesse?

ScholarIQrecord summary

Centre François Baclesse is a research organisation in Esch-sur-Alzette, LU. OpenAlex records 1,774 works and 81,576 citations for it. 526 researchers list it as their most recent affiliation.

How many works does Centre François Baclesse have?

ScholarIQindexed works

Centre François Baclesse has 1,774 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Centre François Baclesse →

How many citations does Centre François Baclesse have?

ScholarIQcitation count

Centre François Baclesse has 81,576 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Centre François Baclesse →

How many researchers are at Centre François Baclesse?

ScholarIQresearcher count

Centre François Baclesse has 526 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Centre François Baclesse?

ScholarIQavg h-index

Centre François Baclesse has an average h-index of 78.5 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Centre François Baclesse?

ScholarIQror

The ROR for Centre François Baclesse is on the source record.

Open the ROR →

What is the OpenAlex record for Centre François Baclesse?

ScholarIQopenalex

The OpenAlex for Centre François Baclesse is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Centre François Baclesse?

ScholarIQtop researchers by citations

Frank M. Faraci · Nitric Oxide and Endothelin Effects

426 works24,058 citations

Roman Rouzier · Breast Cancer Treatment Studies

776 works23,971 citations

What are the most-cited papers on Centre François Baclesse?

ScholarIQmost cited works

Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer

Kenneth R. Hess, K. Anderson, W. Fraser Symmans, Vicente Valero, Nuhad K. Ibrahim, Jaime Mejia, Daniel J. Booser, Richard L. Theriault, Aman U. Buzdar, Peter J. Dempsey, Roman Rouzier, Nour Sneige, Jeffrey S. Ross, Tatiana Vidaurre, Henry Gómez, Gabriel N. Hortobágyi, Lajos Pusztai

Journal of Clinical Oncology. 2006731 Citations

Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)

Marcos Ballester, Gil Dubernard, Fabrice Lécuru, Denis Heitz, Patrice Mathevet, H. Marret, Denis Querleu, François Golfier, Éric Leblanc, Roman Rouzier, Émile Daraï

The Lancet Oncology. 2011568 Citations

Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis

Marc Bazot, Clarisse Lafont, Roman Rouzier, G Roseau, Isabelle Thomassin‐Naggara, Émile Daraï

Fertility and Sterility. 2008435 CitationsOPEN ACCESS

Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy

Bryan T. Hennessy, Gabriel N. Hortobágyi, Roman Rouzier, Henry M. Kuerer, Nour Sneige, Aman U. Buzdar, Shu Wan Kau, Bruno D. Fornage, Ayşegül A. Şahin, Kristine Broglio, S. Eva Singletary, Vicente Valero

Journal of Clinical Oncology. 2005422 Citations

Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer

Roman Rouzier, Radhika Rajan, Peter J. Wagner, Kenneth R. Hess, David Gold, James Stec, Mark Ayers, Jeffrey S. Ross, Peter Zhang, Thomas A. Buchholz, Henry M. Kuerer, Marjorie Green, Banu Arun, Gabriel N. Hortobágyi, W. Fraser Symmans, Lajos Pusztai

Proceedings of the National Academy of Sciences. 2005411 Citations

How much of the research on Centre François Baclesse is open access?

ScholarIQopen access share

43%OPEN ACCESS

Gold

Green

Hybrid

Bronze

43%

Closed

57%